US2003207409A1PendingUtilityA1
Use of alpha-1,4-glucan lyase for preparation of 1,5-D-anhydrofructose
Est. expiryOct 15, 2013(expired)· nominal 20-yr term from priority
Inventors:Shukun YuKirsten BojsenKarsten Matthias KraghMaja BojkoJohn NielsenJan MarcussenTove Christensen
C12P 19/02C12N 9/00C12N 9/88
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of preparing the sugar 1,5-D-anhydrofructose is described. The method comprises treating an α-1,4-glucan with an α-1,4-glucan lyase wherein the enzyme is used in substantially pure form. In a preferred embodiment, if the glucan contains links other than and in addition to the α-1,4-links, the α-1,4-glucan lyase is used in conjunction with a suitable reagent that can break the other links.
Claims
exact text as granted — not AI-modified1 . A method of preparing the sugar 1,5-D-anhydrofructose comprising treating an α-1,4-glucan with the enzyme α-1,4-glucan lyase characterised in that enzyme is used in substantially pure form.
2 . A method according to claim 1 wherein if the glucan contains links other than and in addition to the α-1,4-link the α-1,4-glucan lyase is used in conjunction with a suitable reagent that can break the other links.
3 . A method according to claim 2 wherein the glucan is starch and a hydrolase, preferably a glucanohydrolase, is used in conjunction with the α-1,4-glucan lyase.
4 . A method according to claim 2 or claim 3 wherein the hydrolase is at least one of pullanase or isoamylase.
5 . A method according to any preceding claim wherein the α-1,4-glucan lyase is bound to a support or, more preferably, is in a dissolved form.
6 . A method according to any preceding claim wherein the enzyme is isolated from either a fungus, preferably Morchella costata or Morchella vulgaris, or from a fungally infected algae, preferably Gracilariopsis lemaneiformis or from algae alone, preferably Gracilariopsis lemaneiformis.
7 . A method according to claim 6 wherein the enzyme is isolated and/or further purified from the fungus or from the fungally infected algae or from algae alone using a gel that is not degraded by the enzyme.
8 . A method according to claim 7 wherein the gel is based on dextrin or derivatives thereof, preferably the gel is a cyclodextrin—more preferably beta-cyclodextrin.
9 . A method according to any of the preceding claims wherein the enzyme comprises the amino acid sequence SEQ. ID. No. 1. or the amino acid sequence SEQ. ID. No. 2 or the amino acid sequence SEQ. ID. No. 5. or the amino acid sequence SEQ. ID. No. 6, or any variant thereof.
10 . A method according to any preceding claim wherein the enzyme is obtained from the expression of a nucleotide sequence coding for the enzyme.
11 . A method according to claim 10 wherein the nucleotide sequence is a DNA sequence.
12 . A method according to claim 11 wherein the DNA sequence comprises a sequence that is the same as, or is complementary to, or has substantial homology with, or contains any suitable codon substitutions for any of those of, SEQ. ID. No. 3 or SEQ. ID. No. 4 or SEQ. ID. No. 7 or SEQ. ID. No. 8.
13 . The method according to claim 3 or any claim dependent thereon wherein the starch is used in high concentration—such as up to about 25% solution.
14 . The method according to any one of the preceding claims wherein the substrate is treated with the enzyme in the presence of a buffer.
15 . The method according to any one of claims 1 to 13 wherein the substrate is treated with the enzyme in the presence of at least substantially pure water.
16 . The method according to any one of the preceding claims wherein the substrate is treated with the enzyme in the absence of a co-factor.
17 . The method according to any one of the preceding claims wherein the enzyme is used in combination with amylopectin or dextrin.
18 . A method of preparing the sugar 1,5-D-anhydrofructose comprising treating an α-1,4-glucan with the enzyme α-1,4-glucan lyase characterised in that enzyme comprises the amino acid sequence SEQ. ID. No. 1. or the amino acid sequence SEQ. ID. No. 2 or the amino acid sequence SEQ. ID. No. 5. or the amino acid sequence SEQ. ED. No. 6, or any variant thereof.
19 . The sugar 1,5-D-anhydrofructose when prepared by the method of the present invention.
20 . The use of a reagent that can increase the hydrophobicity of the reaction medium to increase the stability and activity of the GL enzyme.
21 . Use of AF as an anti-oxidant.
22 . Use of AF as a sweetener.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.